246 related articles for article (PubMed ID: 7527294)
1. Sensitive nested reverse transcription polymerase chain reaction detection of circulating prostatic tumor cells: comparison of prostate-specific membrane antigen and prostate-specific antigen-based assays.
Israeli RS; Miller WH; Su SL; Powell CT; Fair WR; Samadi DS; Huryk RF; DeBlasio A; Edwards ET; Wise GJ
Cancer Res; 1994 Dec; 54(24):6306-10. PubMed ID: 7527294
[TBL] [Abstract][Full Text] [Related]
2. Combined nested reverse transcription-PCR assay for prostate-specific antigen and prostate-specific membrane antigen in detecting circulating prostatic cells.
Zhang Y; Zippe CD; Van Lente F; Klein EA; Gupta MK
Clin Cancer Res; 1997 Jul; 3(7):1215-20. PubMed ID: 9815802
[TBL] [Abstract][Full Text] [Related]
3. Enhanced detection of hematogenous circulating prostatic cells in patients with prostate adenocarcinoma by using nested reverse transcription polymerase chain reaction assay based on prostate-specific membrane antigen.
Loric S; Dumas F; Eschwege P; Blanchet P; Benoit G; Jardin A; Lacour B
Clin Chem; 1995 Dec; 41(12 Pt 1):1698-704. PubMed ID: 7497608
[TBL] [Abstract][Full Text] [Related]
4. Molecular staging of prostate cancer. II. A comparison of the application of an enhanced reverse transcriptase polymerase chain reaction assay for prostate specific antigen versus prostate specific membrane antigen.
Cama C; Olsson CA; Raffo AJ; Perlman H; Buttyan R; O'Toole K; McMahon D; Benson MC; Katz AE
J Urol; 1995 May; 153(5):1373-8. PubMed ID: 7536252
[TBL] [Abstract][Full Text] [Related]
5. Combined nested RT-PCR assay for prostate-specific antigen and prostate-specific membrane antigen in prostate cancer patients: correlation with pathological stage.
Grasso YZ; Gupta MK; Levin HS; Zippe CD; Klein EA
Cancer Res; 1998 Apr; 58(7):1456-9. PubMed ID: 9537248
[TBL] [Abstract][Full Text] [Related]
6. Molecular staging of prostate cancer: comparison of nested reverse transcription polymerase chain reaction assay using prostate specific antigen versus prostate specific membrane antigen as primer.
Okegawa T; Yoshioka J; Morita R; Nutahara K; Tsukada Y; Higashihara E
Int J Urol; 1998 Jul; 5(4):349-56. PubMed ID: 9712443
[TBL] [Abstract][Full Text] [Related]
7. Detection of prostate-specific antigen- or prostate-specific membrane antigen-positive circulating cells in prostatic cancer patients: clinical implications.
Millon R; Jacqmin D; Muller D; Guillot J; Eber M; Abecassis J
Eur Urol; 1999 Oct; 36(4):278-85. PubMed ID: 10473985
[TBL] [Abstract][Full Text] [Related]
8. Quantitative polymerase chain reaction does not improve preoperative prostate cancer staging: a clinicopathological molecular analysis of 121 patients.
Sokoloff MH; Tso CL; Kaboo R; Nelson S; Ko J; Dorey F; Figlin RA; Pang S; deKernion J; Belldegrun A
J Urol; 1996 Nov; 156(5):1560-6. PubMed ID: 8863538
[TBL] [Abstract][Full Text] [Related]
9. Repetitive and site-specific molecular staging of prostate cancer using nested reverse transcriptase polymerase chain reaction for prostate specific antigen and prostate specific membrane antigen.
Koutsilieris M; Lembessis P; Luu-The V; Sourla A
Clin Exp Metastasis; 1999; 17(10):823-30. PubMed ID: 11089880
[TBL] [Abstract][Full Text] [Related]
10. Value of reverse transcription polymerase chain reaction assay in pathological stage T3N0 prostate cancer.
Okegawa T; Noda H; Kato M; Miyata A; Nutahara K; Higashihara E
Prostate; 2000 Aug; 44(3):210-8. PubMed ID: 10906737
[TBL] [Abstract][Full Text] [Related]
11. Detection of circulating tumor cells in patients with prostate cancer using prostate specific membrane-derived primers in the polymerase chain reaction.
Noguchi M; Miyajima J; Itoh K; Noda S
Int J Urol; 1997 Jul; 4(4):374-9. PubMed ID: 9256327
[TBL] [Abstract][Full Text] [Related]
12. Expression of prostate-specific antigen and prostate-specific membrane antigen transcripts in blood cells: implications for the detection of hematogenous prostate cells and standardization.
Gala JL; Heusterspreute M; Loric S; Hanon F; Tombal B; Van Cangh P; De Nayer P; Philippe M
Clin Chem; 1998 Mar; 44(3):472-81. PubMed ID: 9510850
[TBL] [Abstract][Full Text] [Related]
13. Preoperative combined nested reverse transcriptase polymerase chain reaction for prostate-specific antigen and prostate-specific membrane antigen does not correlate with pathologic stage or biochemical failure in patients with localized prostate cancer undergoing radical prostatectomy.
Thomas J; Gupta M; Grasso Y; Reddy CA; Heston WD; Zippe C; Dreicer R; Kupelian PA; Brainard J; Levin HS; Klein EA
J Clin Oncol; 2002 Aug; 20(15):3213-8. PubMed ID: 12149293
[TBL] [Abstract][Full Text] [Related]
14. Prospective analysis of prostate-specific markers in pelvic lymph nodes of patients with high-risk prostate cancer.
Ferrari AC; Stone NN; Eyler JN; Gao M; Mandeli J; Unger P; Gallagher RE; Stock R
J Natl Cancer Inst; 1997 Oct; 89(20):1498-504. PubMed ID: 9337346
[TBL] [Abstract][Full Text] [Related]
15. Sensitive detection of prostatic hematogenous tumor cell dissemination using prostate specific antigen and prostate specific membrane-derived primers in the polymerase chain reaction.
Israeli RS; Miller WH; Su SL; Samadi DS; Powell CT; Heston WD; Wise GJ; Fair WR
J Urol; 1995 Mar; 153(3 Pt 1):573-7. PubMed ID: 7532229
[TBL] [Abstract][Full Text] [Related]
16. Prostate-specific membrane antigen-derived primers in a nested reverse transcription polymerase chain reaction for detecting prostatic cancer cells.
Saimoto A; Saito S; Murai M
Jpn J Cancer Res; 1999 Feb; 90(2):233-9. PubMed ID: 10189895
[TBL] [Abstract][Full Text] [Related]
17. Molecular detection of prostate cells in ejaculate and urethral washings in men with suspected prostate cancer.
Clements JA; Rohde P; Allen V; Hyland VJ; Samaratunga ML; Tilley WD; Lavin MF; Gardiner RA
J Urol; 1999 Apr; 161(4):1337-43. PubMed ID: 10081904
[TBL] [Abstract][Full Text] [Related]
18. Blinded evaluation of reverse transcriptase-polymerase chain reaction prostate-specific antigen peripheral blood assay for molecular staging of prostate cancer.
Gao CL; Maheshwari S; Dean RC; Tatum L; Mooneyhan R; Connelly RR; McLeod DG; Srivastava S; Moul JW
Urology; 1999 Apr; 53(4):714-21. PubMed ID: 10197846
[TBL] [Abstract][Full Text] [Related]
19. Evaluating neoadjuvant therapy effectiveness on systemic disease: use of a prostatic-specific membrane reverse transcription polymerase chain reaction.
Su SL; Heston WD; Perrotti M; Cookson MS; Stroumbakis N; Huyrk R; Edwards E; Brander B; Coke J; Soloway S; Lewis A; Fair WR
Urology; 1997 Mar; 49(3A Suppl):95-101. PubMed ID: 9123743
[TBL] [Abstract][Full Text] [Related]
20. Prostate specific membrane antigen (PSM) is expressed in various human tissues: implication for the use of PSM reverse transcription polymerase chain reaction to detect hematogenous prostate cancer spread.
Renneberg H; Friedetzky A; Konrad L; Kurek R; Weingärtner K; Wennemuth G; Tunn UW; Aumüller G
Urol Res; 1999; 27(1):23-7. PubMed ID: 10092150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
